Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine

By Cahn Pedro   Vibhagool Asda   Schechter Mauro   Soto-Ramirez Luis   Carosi Giampiero   Smaill Fiona   Jordan Jamie C.   Pharo Cristina E.   Thomas Nicola E.   Steel Helen M.  

Current Medical Research and Opinion, Vol. 20, Iss. 7, 2004-07 ,pp. : 1115-1123

Informa Healthcare

Access to resources Recommend Favorite

HAART-Prolonged Life of HIV-Infected Patients Should Not Be Shortened by Hepatitis C

By Horster S.  

Infection, Vol. 32, Iss. 6, 2004-12 ,pp. : 369-371

Springer Publishing Company

Access to resources Recommend Favorite

Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France

By Bonnet Fabrice   Lewden Charlotte   May Thierry   Heripret Laurence   Jougla Eric   Bevilacqua Sibylle   Costagliola Dominique   Salmon Dominique   Chêne Geneviève   Morlat Philippe   GROUP THE MORTALITÉ 2000 STUDY  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 6-7, 2005-07 ,pp. : 482-487

Informa Healthcare

Access to resources Recommend Favorite

Osteoporosis in HIV-infected patients

By Groger Richard   Quirk Erin   Powderly William  

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 2, 2004-06 ,pp. : 167-173

Humana Press, Inc

Access to resources Recommend Favorite

Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass

By Manfredi Roberto   Sabbatani Sergio   Chiodo Francesco  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 10, 2005-10 ,pp. : 781-783

Informa Healthcare

Access to resources Recommend Favorite